EZR
Basic information
Region (hg38): 6:158765741-158819368
Previous symbols: [ "VIL2" ]
Links
Phenotypes
GenCC
Source:
- autosomal recessive non-syndromic intellectual disability (Supportive), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EZR gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 23 | ||||
missense | 35 | 39 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 3 | 7 | |||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 19 | 7 |
Variants in EZR
This is a list of pathogenic ClinVar variants found in the EZR region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-158766935-G-A | EZR-related disorder | Likely benign (Dec 12, 2017) | ||
6-158766974-C-T | not specified | Likely benign (Jul 19, 2023) | ||
6-158766991-G-A | not specified | Uncertain significance (Mar 13, 2023) | ||
6-158767020-A-T | not specified | Uncertain significance (Dec 15, 2023) | ||
6-158767021-T-C | not specified | Uncertain significance (Dec 15, 2023) | ||
6-158767035-CT-TC | EZR-related disorder | Uncertain significance (Nov 11, 2022) | ||
6-158767039-T-C | EZR-related disorder | Uncertain significance (Nov 11, 2022) | ||
6-158767050-C-T | not specified | Uncertain significance (Dec 04, 2023) | ||
6-158767069-T-C | not specified | Uncertain significance (Jul 14, 2021) | ||
6-158767077-G-A | not specified | Uncertain significance (Aug 05, 2016) | ||
6-158767271-C-T | not specified | Uncertain significance (Jun 27, 2022) | ||
6-158767272-G-A | not specified | Uncertain significance (Mar 31, 2017) | ||
6-158767284-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
6-158767331-C-T | not specified | Uncertain significance (May 20, 2024) | ||
6-158767376-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
6-158767377-C-G | Benign (Dec 31, 2019) | |||
6-158767393-G-C | not specified | Uncertain significance (Jun 22, 2024) | ||
6-158767417-C-T | Likely benign (Dec 31, 2019) | |||
6-158767423-G-A | not specified | Likely benign (Aug 30, 2019) | ||
6-158767431-G-C | not specified | Uncertain significance (Sep 18, 2017) | ||
6-158767435-T-A | not specified | Likely benign (Dec 31, 2019) | ||
6-158767438-T-G | not specified | Likely benign (Jan 05, 2016) | ||
6-158767445-G-A | Likely benign (May 16, 2018) | |||
6-158767505-T-G | not specified | Uncertain significance (Dec 21, 2022) | ||
6-158767507-T-C | not specified | Likely benign (Oct 20, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EZR | protein_coding | protein_coding | ENST00000367075 | 13 | 53672 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.180 | 0.820 | 125720 | 0 | 28 | 125748 | 0.000111 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.984 | 307 | 360 | 0.854 | 0.0000231 | 3887 |
Missense in Polyphen | 66 | 115.49 | 0.57148 | 1405 | ||
Synonymous | -1.82 | 165 | 138 | 1.20 | 0.00000853 | 1044 |
Loss of Function | 4.01 | 8 | 32.8 | 0.244 | 0.00000157 | 386 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.000100 | 0.0000992 |
East Asian | 0.000384 | 0.000381 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000798 | 0.0000703 |
Middle Eastern | 0.000384 | 0.000381 |
South Asian | 0.000163 | 0.000131 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probably involved in connections of major cytoskeletal structures to the plasma membrane. In epithelial cells, required for the formation of microvilli and membrane ruffles on the apical pole. Along with PLEKHG6, required for normal macropinocytosis. {ECO:0000269|PubMed:17881735, ECO:0000269|PubMed:18270268, ECO:0000269|PubMed:19111582}.;
- Pathway
- Tight junction - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);Pathogenic Escherichia coli infection;AGE-RAGE pathway;VEGFA-VEGFR2 Signaling Pathway;Regulation of Actin Cytoskeleton;Developmental Biology;RAGE;Recycling pathway of L1;ucalpain and friends in cell spread;cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;mcalpain and friends in cell motility;KitReceptor;Netrin-1 signaling;L1CAM interactions;Axon guidance;FAS (CD95) signaling pathway;Syndecan-2-mediated signaling events;RhoA signaling pathway;LKB1 signaling events
(Consensus)
Recessive Scores
- pRec
- 0.721
Intolerance Scores
- loftool
- 0.0624
- rvis_EVS
- -1.2
- rvis_percentile_EVS
- 5.79
Haploinsufficiency Scores
- pHI
- 0.643
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.588
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ezr
- Phenotype
- growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype; digestive/alimentary phenotype;
Zebrafish Information Network
- Gene name
- ezrb
- Affected structure
- pronephric tubule
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;intestinal D-glucose absorption;sphingosine-1-phosphate receptor signaling pathway;cytoskeletal anchoring at plasma membrane;leukocyte cell-cell adhesion;axon guidance;regulation of cell shape;regulation of cell size;positive regulation of gene expression;protein kinase A signaling;gland morphogenesis;membrane to membrane docking;microvillus assembly;astral microtubule organization;actin cytoskeleton reorganization;receptor internalization;regulation of microvillus length;regulation of actin cytoskeleton organization;cellular protein-containing complex localization;positive regulation of multicellular organism growth;cortical microtubule organization;establishment of epithelial cell apical/basal polarity;filopodium assembly;phosphatidylinositol-mediated signaling;positive regulation of protein secretion;negative regulation of T cell receptor signaling pathway;actin filament bundle assembly;establishment of centrosome localization;establishment of endothelial barrier;negative regulation of ERK1 and ERK2 cascade;cellular response to cAMP;protein localization to plasma membrane;protein localization to cell cortex;negative regulation of interleukin-2 secretion;regulation of NIK/NF-kappaB signaling;regulation of organelle assembly;terminal web assembly;positive regulation of protein localization to early endosome;positive regulation of protein localization to plasma membrane;positive regulation of cellular protein catabolic process;negative regulation of p38MAPK cascade;positive regulation of early endosome to late endosome transport
- Cellular component
- fibrillar center;ruffle;immunological synapse;uropod;extracellular space;cytoplasm;endosome;cytosol;actin filament;plasma membrane;microvillus;brush border;focal adhesion;actin cytoskeleton;membrane;basolateral plasma membrane;apical plasma membrane;extrinsic component of membrane;filopodium;T-tubule;cortical cytoskeleton;microvillus membrane;vesicle;ruffle membrane;protein-containing complex;ciliary basal body;cell projection;myelin sheath;cell body;microspike;plasma membrane raft;apical part of cell;perinuclear region of cytoplasm;cell tip;extracellular exosome;invadopodium;cell periphery;astrocyte projection;Schwann cell microvillus;cytoplasmic side of apical plasma membrane
- Molecular function
- RNA binding;actin binding;protein binding;microtubule binding;protein C-terminus binding;protein domain specific binding;protein kinase A catalytic subunit binding;protein kinase A regulatory subunit binding;identical protein binding;S100 protein binding;cadherin binding;cell adhesion molecule binding;actin filament binding;protein kinase A binding;ATPase binding;disordered domain specific binding